RNS Number : 7843C

Kanabo Group PLC

25 February 2022

Kanabo Group Plc

("Kanabo" or the "Company")

Director/PDMR Dealing

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company focussing on the development and distribution of cannabis-derived products for medical patients and wellness CBD consumers, announces Daniel Poulter, Non- Executive Director, has purchased 55,000 ordinary shares at a price of 7.4p.

Avihu Tamir, CEO, commented: "Since joining Kanabo in June 2021 Dan has become an invaluable member of the board. I welcome his most recent show of support by acquiring shares in the market. With the recent acquisition of the GP Service, and completion of an oversubscribed fundraise, Kanabo has approximately GBP6.4m and is well positioned to implement its growth strategy".

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

For further information, please visit http://www.kanabogroup.com/ or contact the following:

 Kanabo Group Plc                    Via Vox Markets 
 Avihu Tamir, CEO 
 Peterhouse Capital Ltd (Financial   Tel: +44 (0)20 7469 0930 
 Eran Zucker / Lauren Riley 
 Peterhouse Capital Ltd (Corporate   Tel: +44 (0)20 7469 0930 
 Lucy Williams / Charles Goodfellow 
 Vox Markets (Investor Relations)    KanaboGroup@voxmarkets.co.uk 
 Kat Perez                           kperez@voxmarkets.co.uk 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name 
        Daniel Poulter 
      ---------------------------------------  --------------------------------------- 
 2     Reason for the notification 
 a)    Position/status                          Non-Executive Director 
      ---------------------------------------  --------------------------------------- 
 b)    Initial notification                     Initial notification 
      ---------------------------------------  --------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer, or auction monitor 
 a)    Name                                     Kanabo Group Plc 
      ---------------------------------------  --------------------------------------- 
 b)    LEI                                      213800XPJFSNWJIYKN52 
      ---------------------------------------  --------------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
 a)    Description of the                       Ordinary Shares of 2.5 pence each 
        financial instrument,                    in Kanabo Group Plc 
        type of instrument 
       Identification code                      GB00BYQCS703 
 b)    Nature of the transaction                Purchase of shares 
      ---------------------------------------  --------------------------------------- 
 c)    Price(s) and volume(s) 
                                                -----------------  ----------------- 
                                                 Price(s)           Volume(s) 
                                                -----------------  ----------------- 
                                                 7.4p               55,000 
                                                -----------------  ----------------- 
 d)    Aggregated information 
  - Aggregated volume                      55,000 
  - Price                                  GBP4,053 
 e)    Date of the transaction                  24/02/2022 
      ---------------------------------------  --------------------------------------- 
 f)    Place of the transaction                 Standard List of the Main Market 
      ---------------------------------------  --------------------------------------- 

Following the share purchase, Mr Poulter's beneficial interests in the capital of the Company is 0.013%.

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers. It has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

February 25, 2022 02:01 ET (07:01 GMT)

Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De May 2022 a Jun 2022 Haga Click aquí para más Gráficas Kanabo.
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Jun 2021 a Jun 2022 Haga Click aquí para más Gráficas Kanabo.